- Home
- IDYA vs VSCO Comparison
IDYA vs VSCO Comparison
Compare IDYA & VSCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDYA
- VSCO
- Stock Information
- Founded
- IDYA 2015
- VSCO 1977
- Country
- IDYA United States
- VSCO United States
- Employees
- IDYA N/A
- VSCO N/A
- Industry
- IDYA Biotechnology: Pharmaceutical Preparations
- VSCO Clothing/Shoe/Accessory Stores
- Sector
- IDYA Health Care
- VSCO Consumer Discretionary
- Exchange
- IDYA Nasdaq
- VSCO Nasdaq
- Market Cap
- IDYA 2.3B
- VSCO 2.1B
- IPO Year
- IDYA 2019
- VSCO N/A
- Fundamental
- Price
- IDYA $26.88
- VSCO $30.23
- Analyst Decision
- IDYA Buy
- VSCO Hold
- Analyst Count
- IDYA 15
- VSCO 12
- Target Price
- IDYA $47.92
- VSCO $26.50
- AVG Volume (30 Days)
- IDYA 1.2M
- VSCO 2.3M
- Earning Date
- IDYA 11-03-2025
- VSCO 08-28-2025
- Dividend Yield
- IDYA N/A
- VSCO N/A
- EPS Growth
- IDYA N/A
- VSCO 6.76
- EPS
- IDYA N/A
- VSCO 1.86
- Revenue
- IDYA $7,000,000.00
- VSCO $6,265,000,000.00
- Revenue This Year
- IDYA $63.41
- VSCO $3.84
- Revenue Next Year
- IDYA $305.49
- VSCO $2.44
- P/E Ratio
- IDYA N/A
- VSCO $16.24
- Revenue Growth
- IDYA N/A
- VSCO 2.29
- 52 Week Low
- IDYA $13.45
- VSCO $13.76
- 52 Week High
- IDYA $32.67
- VSCO $48.73
- Technical
- Relative Strength Index (RSI)
- IDYA 59.69
- VSCO 63.31
- Support Level
- IDYA $26.77
- VSCO $28.04
- Resistance Level
- IDYA $28.41
- VSCO $30.00
- Average True Range (ATR)
- IDYA 0.92
- VSCO 1.08
- MACD
- IDYA 0.04
- VSCO 0.05
- Stochastic Oscillator
- IDYA 59.24
- VSCO 70.47
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
About VSCO Victorias Secret & Co.
Victoria's Secret & Co is a retailer of women's intimate and other apparel and beauty products marketed under the Victoria's Secret, PINK, and Adore Me brand names. It also includes the merchandise sourcing and production function serving the Company and its international partners. The Company operates as a single segment designed to serve customers seamlessly through stores and online channels.